This was one of my previous posts re-timing. You need to add four weeks to each of the dates after Feb because my guess at the start date was one month too optimistic.
Also the trial is a Pl/ll and so it is measuring both safety and efficacy, however, the first to cohort doses are not considered to be therapeutic and so efficacy (Pll) data is only likely to be meaningful after cohort three has been dosed and monitored.
15 Jan - on-going: Start recruiting and screening patients 15 Jan - 01 Feb: Seeks approval of ethics committees 04 Feb dose 1st patient cohort 1 25 March dose second patient cohort 1 13 May dose 1st patient cohort 2 26 May announce preliminary safety results and commencement of dosing Cohort 2 02 July dose patients 2/3 cohort 2 27 Aug dose 1st patient cohort 3 15 Oct dose patients 2/3 cohort 3 03 Dec dose 1st patient cohort 4 25 Feb 2015 dose patients 2/3 cohort 4 20 May dose 1st patient cohort 5 15 Jul dose patients 2/3 cohort 5 16 Sept Final data collection
BLT Price at posting:
$1.81 Sentiment: None Disclosure: Held